Vivendi SE (VVU)
XETRA Stock Exchange · Germany · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 1.561 |
|---|---|
| 52-week range | 1.412 – 3.095 |
| Return, 1 month / 3 months | +4.8% / −17.8% |
| Return, 1 year / 3 years | −48.6% / −21.9% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 46.2% |
| Worst drawdown (1 year) | -54.1% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vivendi is a French media and entertainment group based in Paris. Through its businesses it produces and distributes television content, operates pay-television and streaming services, publishes video games, and runs communications and advertising activities. Its customers include television viewers, subscribers, advertisers, and gaming audiences, mainly in France and other European markets, with some operations reaching further afield. The group has also held stakes in music and telecom businesses.
Vivendi SE trades under the code VVU on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vivendi SE (VVU) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 1.561 on 19 October 2026.
Its price-based Market X-Ray is 20 out of 100 (a weak price profile), ranking 622 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 48.6% and over the last three months it fell 17.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 12 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.4% | ||
| From 52-week high | -49.6% | ||
| Momentum | 11 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.8% | ||
| 6-month return | -30.6% | ||
| 12-month return, skipping the last month | -50.9% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 46.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.1% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +6.1% |
|---|---|
| 1 month | +4.8% |
| 3 months | −17.8% |
| 6 months | −30.6% |
| 1 year | −48.6% |
| 3 years | −21.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.539 / 1.960 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.032 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Apr 2026 | EUR 0.0400 |
| 29 Apr 2025 | EUR 0.0400 |
| 30 Apr 2024 | EUR 0.2500 |
| 25 Apr 2023 | EUR 0.2500 |
| 26 Apr 2022 | EUR 0.2500 |
| 23 Jun 2021 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.